Clinical Trials Directory

Trials / Conditions / Hypoglycemic Agents

Hypoglycemic Agents

8 registered clinical trials studyying Hypoglycemic Agents.

StatusTrialSponsorPhase
CompletedEvaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD)
NCT06145360
SINA Health Education and Welfare TrustPhase 4
CompletedA Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
NCT04809220
Eli Lilly and CompanyPhase 3
TerminatedEfficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
NCT04371978
Rabin Medical CenterPhase 3
UnknownAnalysis of Ergogenic Potential and Risks Associated With Acute and Chronic Use of Sulphonylureas on Physical
NCT04443777
Instituto de Cardiologia do Rio Grande do SulPhase 4
CompletedSodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production
NCT03852901
National Institute on Aging (NIA)Phase 1
CompletedAntidiabetic Drugs for Steatotic Liver Disease
NCT03646292
Yonsei UniversityPhase 4
UnknownThe Effects of Empagliflozin on Arterial Wall Characteristics
NCT03639545
University Medical Centre LjubljanaPhase 4
UnknownEffects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes
NCT01867502
Hospital de Clinicas de Porto AlegrePhase 4